ReviewOncology letters2021
Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer.
Yujian Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewOncology letters2021
Yujian Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.